A drug that cures hepatitis B has been approved.
Bepirovirsen was developed by the British pharmaceutical company GlaxoSmithKline (GSK). The drug is an antisense oligonucleotide. These molecules target the virus's RNA and prevent its genetic information from being released. Furthermore, the drug may stimulate the immune system...
